高级检索
当前位置: 首页 > 详情页

Comparison of Orcinoside With Placebo in Treatment of MDD

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Shanghai Mental Health Center [2]First Affiliated Hospital of Kunming Medical University Kunming,Yunnan,China,650032 [3]Xi'an Mental Health Center Xi'an,Shanxi,China,710061 [4]Peking University Sixth Hospital Beijing,Beijing,China,100191 [5]Guangzhou Brain Hospital Guangzhou,Guangdong,China,510370 [6]Hebei Province Mental Health Center Baoding,Hebei,China,071000 [7]Wuhan Mental Health Center Wuhan,Hubei,China,430022 [8]Nanjing Brain Hospital Nanjing,Jiangsu,China,210029 [9]Wuxi Mental Health Center Wuxi,Jiangsu,China,214151 [10]Shanghai Mental Health Center Shanghai,Shanghai,China,200030

研究目的:
The purpose of this study is to determine whether Orcinoside Capsule in different doses are effective in the treatment of Depression. And to explore the preliminary information of safety and efficacy of Orcinoside Capsule in the Chinese Patients with Depression.

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)